GLOBAL HUMAN COMBINATION VACCINES MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Jan 2019 116

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.

Scope of the Report:
This report focuses on the Human Combination Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The increase in pediatric population is one of the primary growth factors for this market. With the increase in pediatric population, the demand for combination vaccines for immunization is higher as newborn infants are more vulnerable to various infectious diseases due to weak immune systems. These vaccines help reduce the number of shots and healthcare center visits, which consequently save time and money. It has been observed that the occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles is high among children in developing nations.
The Americas is expected to be the major revenue contributor to the market by 2023. The introduction of strict regulatory norms that recommend proper vaccination of infants and the continuous efforts by vendors and national organizations to promote the use of human combination vaccines, will drive the market’s growth prospects in the Americas.
The worldwide market for Human Combination Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- GlaxoSmithKline
- Merck
- Sanofi
- Daiichi Sankyo
- Serum Institute of India
- Takeda Pharmaceuticals

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Human Combination Inactivated Vaccines
- Human Combination Live Attenuated Vaccines

Market Segment by Applications, can be divided into
- Hospitals
- Clinics
- Others

There are 15 Chapters to deeply display the global Human Combination Vaccines market.
Chapter 1, to describe Human Combination Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Combination Vaccines, with sales, revenue, and price of Human Combination Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Combination Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Combination Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Combination Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Jan 19)

POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Scope of the Report...

(Jan 19)

Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. Sc...

(Jan 19)

Plasma, pale yellow in color, is the component of the blood. Scope of the Report: This report focuses on the Plasma Th...

(Jan 19)

Physiotherapy is a nonsurgical treatment method, where the treatment for impairments such as injury, deformity. Scope of the ...

(Jan 19)

Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes rou...

(Jan 19)

Sleeping aids are defined as products or devices used to facilitate sleep in individuals with various sleep disorders. Sleeping aids include...

GLOBAL HUMAN COMBINATION VACCINES MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy